Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

The FDA is Making Rules for AI in Medicine

The Agency announced that it is developing a regulation system for artificial intelligence products used in medicine.

AI / Image: Adobe
AI / Image: Adobe

No one really knows how artificial intelligence will affect culture and society, but there’s no shortage of theories. From increased productivity to doomsday scenarios, every outcome has been explored in sci-fi movies. A recent Stat News article said the FDA wants to take some guesswork out of the equation by creating greater oversight over the quickly evolving segment of AI products in medicine that constantly change based on exposure to new patients and data.

Scott Gottlieb, the current (but not for long) commissioner of the FDA, released a white paper that outlined the agency’s approach. The main thesis of the paper is to establish when AI-driven medical products will need FDA review before they’re commercialized. A review may look at the underlying performance of a product’s algorithms, a manufacturer’s plan for modifications, and the manufacturer’s ability to manage the risks that come with them.

“Artificial intelligence has helped transform industries like finance and manufacturing, and I’m confident that these technologies will have a profound and positive impact on health care,” Gottlieb wrote. “I can envision a world where, one day, artificial intelligence can help detect and treat challenging health problems, for example by recognizing the signs of disease well in advance of what we can do today.”

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?